← Back to Search

Imaging Techniques for Hip Surgery Assessment

N/A
Recruiting
Led By David MacLeod
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Primary hip replacement
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1, up to 1 hour
Awards & highlights
No Placebo-Only Group

Summary

This trial will compare muscle area & IMAT content of thigh muscles measured by CT & MSK ultrasound in hip replacement patients. It will compare two methods of measuring muscle area & IMAT content to assess muscle quality.

Who is the study for?
This trial is for patients scheduled for primary hip replacement surgery. It aims to compare muscle quality assessments using two different imaging techniques: CT scans and handheld ultrasound.
What is being tested?
The study is testing the effectiveness of musculoskeletal (MSK) ultrasound against standard CT imaging in measuring muscle area and fat within muscles (IMAT) in the thigh, specifically in patients undergoing hip arthroplasty.
What are the potential side effects?
CT scans involve exposure to X-rays, which carry a risk of radiation. Ultrasound does not use ionizing radiation and is considered safe with no known side effects related to this procedure.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1, up to 1 hour
This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1, up to 1 hour for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
%IMAT
All IMAT

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: UltrasoundExperimental Treatment1 Intervention
Patients have ultrasound scans together with standard of care CT prior to primary hip replacement
Group II: CTActive Control1 Intervention
Patients have standard of care CT prior to primary hip replacement
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Ultrasound
2013
Completed Phase 1
~4090

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,463 Previous Clinical Trials
2,981,820 Total Patients Enrolled
David MacLeodPrincipal InvestigatorDuke University

Media Library

CT Clinical Trial Eligibility Overview. Trial Name: NCT04126161 — N/A
Metabolic Muscle Profiling Research Study Groups: CT, Ultrasound
Metabolic Muscle Profiling Clinical Trial 2023: CT Highlights & Side Effects. Trial Name: NCT04126161 — N/A
CT 2023 Treatment Timeline for Medical Study. Trial Name: NCT04126161 — N/A
~2 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top